Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Fosbretabulin tromethamine

EU orphan designation number: EU/3/16/1633   
Active ingredient: Fosbretabulin tromethamine
Indication: Treatment of gastro-entero-pancreatic neuroendocrine tumours
Sponsor: Diamond ROC EOOD
Bul. Gen. Totleben 53-55, Office 311, Kriva Reka, Sofia 1606, България

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/03/2016 Orphan designation EMA/OD/211/15 (2016)1870 of 21/03/2016
18/03/2019 Transfer of orphan designation EMA/OD/0000003815 (2019)2151 of 14/03/2019